Dermata Therapeutics's total assets for Q1 2025 were $10.01M, an increase of 183.12% from the previous quarter. DRMA total liabilities were $2.70M for the fiscal quarter, a 37.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.